EHA 2017: A Discussion of Ibrutinib vs. Real-World Treatment in Patients with Treatment-Naive CLL NE Live 4:18 7 years ago 487 Далее Скачать
First-line ibrutinib vs chemoimmunotherapy in CLL: a real-world data analysis VJHemOnc – Video Journal of Hematology & HemOnc 4:29 4 years ago 114 Далее Скачать
Evaluation 17p del CLL patients treated with ibrutinib: cross-study analysis of treatment outcomes VJHemOnc – Video Journal of Hematology & HemOnc 4:02 8 years ago 251 Далее Скачать
Real-world analysis of the impact of del(17p) on ibrutinib efficacy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:01 4 years ago 88 Далее Скачать
Real-World Support for Ibrutinib as a Treatment for High-Risk CLL CheckRare 5:29 4 years ago 234 Далее Скачать
Real-world comparison of TTNT with ibrutinib or acalabrutinib in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:29 6 months ago 120 Далее Скачать
MAIC of zanubrutinib and venetoclax + ibrutinib in treatment-naïve CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:03 6 months ago 122 Далее Скачать
Matching-adjusted indirect comparisons of acalabrutinib vs ibrutinib in treatment-naïve CLL VJHemOnc – Video Journal of Hematology & HemOnc 3:20 4 years ago 1 245 Далее Скачать
The outcomes of intensive treatment for patients with AML who have failed venetoclax-based therapy VJHemOnc – Video Journal of Hematology & HemOnc 2:22 2 days ago 64 Далее Скачать
Acalabrutinib May Be an Alternative to Ibrutinib For Treatment of CLL Targeted Oncology 1:37 5 years ago 744 Далее Скачать
Front-line use of ibrutinib for CLL in a real-world setting VJHemOnc – Video Journal of Hematology & HemOnc 1:38 6 years ago 198 Далее Скачать
Real World Data Shows Ibrutinib May Be Superior to Acalabrutinib in CLL Patients CheckRare 8:20 2 years ago 515 Далее Скачать
CLL: Long-term updates on ibrutinib and idelalisib HMP Education 25:09 6 years ago 2 195 Далее Скачать
Comparing outcomes of first-line ibrutinib vs chemoimmunotherapy in high-risk CLL ecancer 4:59 4 years ago 51 Далее Скачать
Dr. Pinilla-Ibarz on Ibrutinib's Efficacy in Treating High-Risk Patients With CLL OncLive 0:55 7 years ago 374 Далее Скачать
Real-world data on the effect of ibrutinib flexible dosing treatment strategies on TTNT in CLL/SLL VJHemOnc – Video Journal of Hematology & HemOnc 6:05 10 months ago 61 Далее Скачать
Does acalabrutinib increase the risk of hypertension in patients with CLL? VJHemOnc – Video Journal of Hematology & HemOnc 1:22 1 year ago 149 Далее Скачать
4 years of RESONATE data for CLL patients treated with ibrutinib ecancer 1:40 7 years ago 97 Далее Скачать
